343 related articles for article (PubMed ID: 31213534)
1. I-branched carbohydrates as emerging effectors of malignant progression.
Dimitroff CJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):13729-13737. PubMed ID: 31213534
[TBL] [Abstract][Full Text] [Related]
2. Loss of GCNT2/I-branched glycans enhances melanoma growth and survival.
Sweeney JG; Liang J; Antonopoulos A; Giovannone N; Kang S; Mondala TS; Head SR; King SL; Tani Y; Brackett D; Dell A; Murphy GF; Haslam SM; Widlund HR; Dimitroff CJ
Nat Commun; 2018 Aug; 9(1):3368. PubMed ID: 30135430
[TBL] [Abstract][Full Text] [Related]
3. Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans.
Giovannone N; Liang J; Antonopoulos A; Geddes Sweeney J; King SL; Pochebit SM; Bhattacharyya N; Lee GS; Dell A; Widlund HR; Haslam SM; Dimitroff CJ
Nat Commun; 2018 Aug; 9(1):3287. PubMed ID: 30120234
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation, galectins and cellular signaling.
Boscher C; Dennis JW; Nabi IR
Curr Opin Cell Biol; 2011 Aug; 23(4):383-92. PubMed ID: 21616652
[TBL] [Abstract][Full Text] [Related]
5. Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
Compagno D; Gentilini LD; Jaworski FM; Pérez IG; Contrufo G; Laderach DJ
Glycobiology; 2014 Oct; 24(10):899-906. PubMed ID: 24939371
[TBL] [Abstract][Full Text] [Related]
6. Galectin-Binding O-Glycosylations as Regulators of Malignancy.
Dimitroff CJ
Cancer Res; 2015 Aug; 75(16):3195-202. PubMed ID: 26224120
[TBL] [Abstract][Full Text] [Related]
7. Rho GTPase Rac1: molecular switch within the galectin network and for N-glycan α2,6-sialylation/O-glycan core 1 sialylation in colon cancer in vitro.
André S; Singh T; Lacal JC; Smetana K; Gabius HJ
Folia Biol (Praha); 2014; 60(3):95-107. PubMed ID: 25056432
[TBL] [Abstract][Full Text] [Related]
8. N-Glycans in cancer progression.
Lau KS; Dennis JW
Glycobiology; 2008 Oct; 18(10):750-60. PubMed ID: 18701722
[TBL] [Abstract][Full Text] [Related]
9. Glycans as a key factor in self and nonself discrimination: impact on the breach of immune tolerance.
Alves I; Fernandes Â; Santos-Pereira B; Azevedo CM; Pinho SS
FEBS Lett; 2022 Jun; 596(12):1485-1502. PubMed ID: 35383918
[TBL] [Abstract][Full Text] [Related]
10. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
[TBL] [Abstract][Full Text] [Related]
11. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
12. Glycans in melanoma screening. Part 2. Towards the understanding of integrin N-glycosylation in melanoma.
Link-Lenczowski P; Lityńska A
Biochem Soc Trans; 2011 Jan; 39(1):374-7. PubMed ID: 21265807
[TBL] [Abstract][Full Text] [Related]
13. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
14. N-linked polylactosamine glycan synthesis is regulated by co-expression of β3GnT2 and GCNT2.
Henion TR; Schwarting GA
J Cell Physiol; 2014 Apr; 229(4):471-8. PubMed ID: 24105809
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell N-glycans in metastasis.
Laidler P; Lityńska A
Acta Biochim Pol; 1997; 44(2):343-57. PubMed ID: 9360725
[TBL] [Abstract][Full Text] [Related]
16. Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection.
Pinho SS; Alves I; Gaifem J; Rabinovich GA
Cell Mol Immunol; 2023 Oct; 20(10):1101-1113. PubMed ID: 37582971
[TBL] [Abstract][Full Text] [Related]
17. Unique Binding Specificities of Proteins toward Isomeric Asparagine-Linked Glycans.
Gao C; Hanes MS; Byrd-Leotis LA; Wei M; Jia N; Kardish RJ; McKitrick TR; Steinhauer DA; Cummings RD
Cell Chem Biol; 2019 Apr; 26(4):535-547.e4. PubMed ID: 30745240
[TBL] [Abstract][Full Text] [Related]
18. Glycan Chains of Gangliosides: Functional Ligands for Tissue Lectins (Siglecs/Galectins).
Ledeen RW; Kopitz J; Abad-Rodríguez J; Gabius HJ
Prog Mol Biol Transl Sci; 2018; 156():289-324. PubMed ID: 29747818
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.
Perez M; Chakraborty A; Lau LS; Mohammed NBB; Dimitroff CJ
Br J Dermatol; 2021 Aug; 185(2):294-301. PubMed ID: 33660254
[TBL] [Abstract][Full Text] [Related]
20. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
Ferdosi S; Rehder DS; Maranian P; Castle EP; Ho TH; Pass HI; Cramer DW; Anderson KS; Fu L; Cole DEC; Le T; Wu X; Borges CR
J Proteome Res; 2018 Jan; 17(1):543-558. PubMed ID: 29129073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
